home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

Webinar On Understanding the FDA’s Quality System Regulation, 21 CFR, Part 820

 
  August 07, 2015  
     
 


Compliance Trainings, Online
2015-08-19


Description :

Compliance with 21 CFR, Part 820 (the FDA’s Quality System Regulation) is not optional for device manufacturers wanting to enter medical devices into commerce in the United States. Compliance is driven, in part, by device classification (three device classes in the U.S.). However, many device manufacturers entering products into commerce for the first time struggle to understand what is actually required for compliance.

If your organization is struggling with understanding the salient requirements associated with 21 CFR, Part 820, this webinar is for you. This webinar will help your organizations better understand the FDA’s expectations for implementing a Quality Management System (QMS), while providing insight into tools needed for establishing an effective approach to quality management. For establishments already having a compliant QMS, this webinar will help your organization streamline their approach to Quality Management.

Areas Covered in the Session :

Reviewing and understanding the requirements associated with 21 CFR, Part 820 compliance.

Regulatory and statutory requirements.

Similarities with ISO 13485:2003.

Device Classification.

Establishing QMS processes and procedures.

Documented evidence of compliance.

The importance of procedures and record collection.

Employing CAPA to drive QMS improvements.

The FDA’s inspection process.

Form 483 – inspectional observations.

The FDA Warning Letter process.

Who Will Benefit:

A must attend webinar for all industry professionals, regardless of functional roles, will benefit from this training, especially if you are involved in the day-to-day activities associated with supporting your organization’s QMS. The staff who will benefit include:

Quality Professionals

Regulatory Professionals

Test Technicians

R & D Engineers

Manufacturing Engineers

 

Quality Engineers

 
 
Organized by: Compliance Trainings
Invited Speakers:

Dr. Christopher Joseph Devine is the president and founder of Devine Guidance International, Inc., (DGII) a consulting firm providing regulatory and quality compliance support for the medical device industry. Prior to launching DGII, Dr. D spent 14-years with Boston Scientific Corporation working in a variety of quality and regulatory management roles. Additionally, Dr. Devine is the author of Devine Guidance, a weekly blog focusing on quality and regulatory compliance issues facing the medical device industry; and published by the Medical Device Summit, an e-magazine.

 
Deadline for Abstracts: 2015-08-18
 
Registration:

For more information about this event please visit

https://compliancetrainings.com/SiteEngine/ProductDetailView.aspx?id=MD1446

Speaker Profile

E-mail: suzzane.d@compliancetrainings.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.